Several analysts have already issued a rating of hold on the stocks of EVOP, with nine of the investment analysts covering the firm. According to reports, one of the analysts has already given the stocks with a rating of sell, while five of them have given it a rating of hold. Currently, the price target on the firm has been fixed at $24.29- calculated over a period of a year.
The Quarterly Estimates of EVOP
There have been quite a few research equities that have commented on the stocks of EVOP. Zacks has already decreased the rating of the company from hold to sell, in a Wednesday research note. BTIG Research, on the other hand, gave the company a rating of buy, with a price target of $30 set on the company. Compass Point also talked about the rating of hold on EVOP, which was then published in a 16th December research note. In the end, Barclays went ahead to reiterate the rating of hold, along with a $15 price objective which was later published in a 22nd December research report.
The shares of EVOP traded on Friday at $26.45. The market cap of the firm has been set at $2.19 billion, with the PE ratio fixed at -97.96, along with a 1.73 beta. The moving average price of the company over 50 days is $26.96, while the moving average price of the company over 200 days has been set at $25.46. The year high is $30, while the year low has been set at $10.12.
EVOP previously posted its quarterly earnings on the 5th of November. The EPS reported by the company for the quarter was $0.19, which was more than the estimate set by Thomson Reuters at $0.18. The revenue generated by EVOP in this period was $117 million, which was more than the consensus estimate of $116.50 million. Currently, the company shares a negative 1.37% net margin, along with a negative 6.43% return on its equity.